Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives

BMJ 1998; 316 doi: 10.1136/bmj.316.7136.984 (Published 28 March 1998)
Cite this as: BMJ 1998;316:984
  1. Philip C Hannaford (p.hannaford{at}abdn.ac.uk), director,
  2. Vicci Owen-Smith, clinical research fellow
  1. Royal College of General Practitioners' Manchester Research Unit, Parkway House, Manchester M22 4DB
  1. Correspondence to: Dr P C Hannaford, RCGP Centre for Primary Care Research and Epidemiology, Foresterhill Health Centre, Aberdeen AB25 2AY

    Abstract

    Objective: To explore the usefulness of epidemiological data to guide clinical practice by seeking an answer to the question “What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of vascular disease?”

    Design: Review of all relevant published studies identified from the library of references held by Royal College of General Practitioners' Manchester Research Unit, checking of reference lists of identified studies, and Medline search.

    Main outcome measures: Identification of methodologically sound studies able to address the specific clinical question.

    Results: Our literature search identified 74 papers about the relation between current use of combined oral contraceptives and cardiovascular disease: 23 papers reporting risk of venous thromboembolism, 22 on ischaemic stroke, 13 on haemorrhagic stroke or subarachnoid haemorrhage, 13 on all stroke, and 33 on myocardial infarction. Only five papers provided information that directly addressed our clinical question; all related to the risk of venous thromboembolism. Fourteen of the discarded papers probably had the potential to answer our clinical question.

    Conclusions: Much of the epidemiological data about the risk of cardiovascular disease in users of combined oral contraceptives is not useful to clinicians. Some of the discarded data could be made more useful to clinicians by reanalysis. This situation is unlikely to be unique to use of contraceptives.

      THIS WEEK'S POLL